Show Less

Material Transfer Agreements in der Stammzellenforschung- Internationalprivatrechtliche und zivilrechtliche Aspekte

Internationalprivatrechtliche und zivilrechtliche Aspekte

Series:

Yvonne Sada

Der Import embryonaler Stammzellen nach Deutschland erfordert regelmäßig den Abschluss eines Material Transfer Agreements. Die Arbeit zeigt typische Inhalte und Formen solcher Transfervereinbarungen auf und beleuchtet deren rechtstypologische Einordnung in das System der Schuldverträge. Auf dieser Basis erfolgt sodann eine Untersuchung des auf die Material Transfer Agreements anwendbaren Rechts nach der Rom I-Verordnung. Darüber hinaus werden auch sachenrechtliche Aspekte im Zusammenhang mit dem Stammzellenimport beleuchtet. Gelingt dem Materialempfänger in seinen Forschungsprojekten die Weiterentwicklung des Ausgangsmaterials, so stellt sich die Frage, ob und unter welchen Voraussetzungen er hieran Eigentum erlangt.

Prices

Show Summary Details
Restricted access

Annex: Die Transfervereinbarungen

Extract

INSTITUTION MATERIAL TRANSFER AGREEMENT The Regents of the University of California, on behalf of the University of California San Francisco, ("UCSF") agrees to provide the following institution: [___________________ ____________________________] ("Recipient") with human embryonic stem cell line ___, requested by Recipient for use by its scientist, [__________________] ("Recipient Scientist"), subject to the terms and conditions set forth in this Institution Material Transfer Agreement (the "Agreement"). Background 1. Human embryonic stem cell line [ ] (together with its unmodified and undifferentiated progeny and unmodified and undifferentiated derivatives, the "Material") has been derived consistent with the Presidential Statement of August 9, 2001, from the research efforts of Dr. Meri Firpo, Dr. Roger Pedersen, and Juanito Meneses (collectively, "Investigator") of UCSF with funds provided by the State of California under the University of California Discovery Grant/BioSTAR Project and Geron Corporation ("Sponsor") under a Sponsored Research Agreement (the "Research Agreement"). 2. The Material is or may be subject to patent rights owned by the University of Wisconsin or its affiliates ("Wisconsin") concerning primate embryonic stem cells and their cultivation as claimed in U.S. Patent 5,843,780, U.S. Patent 6,200,806, U.S. Patent Application 09/522,030 and corresponding U.S. or foreign patent rights and any patents granted on any divisional and continuation applications, reissues and reexaminations ("Wisconsin Patent Rights"). Sponsor has an exclusive license to Wisconsin Patent Rights for commercial use in certain fields of use. 3. Property rights in the Material are owned by UCSF, and Sponsor has an exclusive license to UCSF's property rights and intellectual property rights...

You are not authenticated to view the full text of this chapter or article.

This site requires a subscription or purchase to access the full text of books or journals.

Do you have any questions? Contact us.

Or login to access all content.